Amwell expects lower revenue in 2026

Core Insights - Amwell has refocused its strategy by consolidating multiple products into a single platform, enhancing its technology-enabled care offerings [3][4] - The company aims for predictable software-as-a-service revenue, which is expected to contribute to its financial stability [4] - Amwell is targeting to break even on cash flow from operations by the fourth quarter of 2026, despite a projected decline in revenue for that year [6] Financial Performance - Amwell narrowed its net loss in 2025 to $95 million, down from a loss of $212.6 million in 2024 [6] - Revenue declined approximately 2% year-over-year, with a significant drop of about 22% in the fourth quarter, attributed to lower revenue from its contract with the Defense Health Agency [6] - The company expects revenue in 2026 to be between $195 million and $205 million, a decrease from $249.3 million in 2025, but characterized as "high-quality, high-upside, sticky revenue" by the CEO [8] Strategic Initiatives - Amwell's major initiative includes a contract with the Defense Health Agency worth up to $180 million, which has faced budget restrictions affecting certain service deployments [7] - The company has divested several assets as part of its strategic shift, which is anticipated to impact revenue projections for 2026 [8]